Vaccine adjuvant formulations play a crucial role in enhancing the immune response to vaccines. CAPVAXIVE™, a pneumococcal 21-valent conjugate vaccine developed by Merck, showcases the importance of effective adjuvants in vaccine design. Adjuvants are added to vaccines to stimulate a stronger and longer-lasting immune response, improving their effectiveness. Understanding the composition and function of adjuvant […]